ANRS, Emerging Infectious Diseases

🇫🇷France

Country: 🇫🇷France

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Study of DAA Treatment for Children and Adolescents With Active HCV Infection in Cambodia

Not Applicable

Recruiting

Conditions: HCV Infection

Interventions: Drug: Sofosbuvir/Daclatasvir

First Posted Date: 2023-08-15

Last Posted Date: 2024-03-26

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 21000

Registration Number: NCT05992077

Locations: 🇰🇭
Jayavarman VII Hospital, Siem Reap, Cambodia
🇰🇭
Battambang Provincial Hospital, Battambang, Cambodia
🇰🇭
Kantha Bopha, Phnom Penh, Cambodia

and more 1 locations

HPV Infection, Sexually Transmitted Infections and Anal Dysplasia in the Transgender Population

Not yet recruiting

Conditions: Sexually Transmitted Diseases
Human Papillomavirus Infection
Human Immunodeficiency Virus Infection

First Posted Date: 2023-08-08

Last Posted Date: 2023-08-08

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 200

Registration Number: NCT05981807

Seroprevalence of Monkeypox Infection Among People Living With HIV and PrEP Users

Not yet recruiting

Conditions: Monkey Pox
HIV Infections

Interventions: Behavioral: Questionnaire

First Posted Date: 2023-06-28

Last Posted Date: 2023-06-28

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 5000

Registration Number: NCT05922735

Drug Use & Infections in ViEtnam: Mental Health Intervention for INjecting Drug Users

Not Applicable

Active, not recruiting

Conditions: Psychiatric Disorder
Drug Use

Interventions: Other: Community-based psychiatric intervention

First Posted Date: 2023-06-02

Last Posted Date: 2024-01-31

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 567

Registration Number: NCT05886504

Locations: 🇻🇳
Mental Health Department, Haiphong, Hai Phong, Vietnam

Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France.

Phase 3

Recruiting

Conditions: HIV/AIDS

Interventions: Drug: TDF/FTC 300mg/200mg fixed-dose combination tablets
Drug: TAF/FTC 25mg/200mg fixed-dose combination tablets

First Posted Date: 2023-04-14

Last Posted Date: 2024-06-06

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 524

Registration Number: NCT05813964

Locations: 🇫🇷
AP-HP - Hôpital Saint-Louis, Paris, France
🇹🇭
STIs Clinic of the Office of Disease Prevention and Control Region 1, Chiang Mai, Thailand

Community Intervention to Eliminate HCV Among People Who Use Drugs.

Not Applicable

Recruiting

Conditions: Substance Use Disorders
HCV

Interventions: Other: Hybrid effectiveness-implementation study type 2

First Posted Date: 2023-04-03

Last Posted Date: 2024-04-08

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 3400

Registration Number: NCT05794646

Locations: 🇫🇷
Paris, Paris, Ile De France, France
🇲🇶
Martinique, Fort-de-France, Martinique
🇫🇷
Marseille, Marseille, Paca, France

and more 1 locations

Pilot Implementation of HIV Self-testing Delivery in Private Pharmacies Combined to a Respondent Driven Sampling Method to Improve HIV Testing for MSM and TGW in Phnom Penh - ANRS 0100s

Not yet recruiting

Conditions: HIV Infections

Interventions: Diagnostic Test: OraQuick

First Posted Date: 2023-02-27

Last Posted Date: 2024-01-30

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 1500

Registration Number: NCT05745168

Locations: 🇰🇭
University of Health Sciences, Phnom Penh, Cambodia

DRug Use & Infections in ViEtnam: TuBerculosis Control

Not Applicable

Recruiting

Conditions: Tuberculosis

Interventions: Other: Community based TB intervention

First Posted Date: 2022-12-19

Last Posted Date: 2023-11-30

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 4000

Registration Number: NCT05655702

Locations: 🇻🇳
Hai Phong University of Medecine and Pharmacy, Hải Phòng, Vietnam
🇻🇳
Viettiep 2 Hospital, Hải Phòng, Vietnam

Assessment of the Efficacy and Safety of Tecovirimat in Patients with Monkeypox Virus Disease

Phase 3

Recruiting

Conditions: Monkeypox
Mpox

Interventions: Drug: Tecovirimat
Drug: Placebo

First Posted Date: 2022-10-28

Last Posted Date: 2024-10-09

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 150

Registration Number: NCT05597735

Locations: 🇨🇭
Pr Alexandra Calmy, Geneva, Switzerland
🇦🇷
Fundación Huésped, Ciudad Autonoma de Buenos Aires, Argentina
🇧🇷
Faculty of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil

and more 9 locations

Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis

Phase 2

Recruiting

Conditions: HIV I Infection
Tuberculous Meningitis

Interventions: Drug: Adalimumab Injection

First Posted Date: 2022-10-21

Last Posted Date: 2023-09-22

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 130

Registration Number: NCT05590455

Locations: 🇲🇿
Instituto Nacional de Saude, Maputo, Mozambique
🇿🇲
Adult Infectious Diseases Centre, University Teaching Hospital, Lusaka, Zambia
🇧🇷
Laboratory of clinical research on STD/AIDS - IPEC/FIOCRUZ, Rio De Janeiro, Brazil

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy